140 related articles for article (PubMed ID: 12843684)
21. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
[TBL] [Abstract][Full Text] [Related]
22. Effect of atorvastatin on the angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ) induced diabetic rats.
Chaudagar KK; Mehta AA
Can J Physiol Pharmacol; 2014 Apr; 92(4):338-49. PubMed ID: 24708217
[TBL] [Abstract][Full Text] [Related]
23. Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats.
Prakash P; Khanna V; Singh V; Jyoti A; Jain M; Keshari RS; Barthwal MK; Dikshit M
Cardiovasc Drugs Ther; 2011 Aug; 25(4):285-97. PubMed ID: 21671014
[TBL] [Abstract][Full Text] [Related]
24. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
[TBL] [Abstract][Full Text] [Related]
25. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
26. Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase.
Wolfrum S; Grimm M; Heidbreder M; Dendorfer A; Katus HA; Liao JK; Richardt G
J Cardiovasc Pharmacol; 2003 Mar; 41(3):474-80. PubMed ID: 12605027
[TBL] [Abstract][Full Text] [Related]
27. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
28. Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property.
Matsuki A; Igawa A; Nozawa T; Nakadate T; Igarashi N; Nonomura M; Inoue H
Circ J; 2006 Dec; 70(12):1643-9. PubMed ID: 17127814
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
Tang XL; Sanganalmath SK; Sato H; Bi Q; Hunt G; Vincent RJ; Peng Y; Shirk G; Dawn B; Bolli R
PLoS One; 2011; 6(9):e25320. PubMed ID: 21980426
[TBL] [Abstract][Full Text] [Related]
31. Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats.
Ren B; Shen Y; Shao H; Qian J; Wu H; Jing H
Clin Chim Acta; 2007 Feb; 377(1-2):83-7. PubMed ID: 17026975
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling.
Efthymiou CA; Mocanu MM; Yellon DM
J Cardiovasc Pharmacol; 2005 Mar; 45(3):247-52. PubMed ID: 15725950
[TBL] [Abstract][Full Text] [Related]
33. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.
Song L; Yang YJ; Dong QT; Qian HY; Gao RL; Qiao SB; Shen R; He ZX; Lu MJ; Zhao SH; Geng YJ; Gersh BJ
PLoS One; 2013; 8(5):e65702. PubMed ID: 23741509
[TBL] [Abstract][Full Text] [Related]
35. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
36. Eicosapentaenoic acid reduces myocardial injury induced by ischemia and reperfusion in rabbit hearts.
Ogita H; Node K; Asanuma H; Sanada S; Takashima S; Minamino T; Soma M; Kim J; Hori M; Kitakaze M
J Cardiovasc Pharmacol; 2003 Jun; 41(6):964-9. PubMed ID: 12775977
[TBL] [Abstract][Full Text] [Related]
37. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Hahn JY; Kim HJ; Choi YJ; Jo SH; Kim HJ; Lee S; Ahn KJ; Song YB; Choi JH; Choi SH; Choi YJ; Lee KH; Lee SH; Gwon HC
Am Heart J; 2011 Dec; 162(6):1026-33. PubMed ID: 22137076
[TBL] [Abstract][Full Text] [Related]
38. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
Pernow J; Wang QD
Acta Physiol Scand; 1999 Oct; 167(2):151-9. PubMed ID: 10571551
[TBL] [Abstract][Full Text] [Related]
39. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
40. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
Ye Y; Lin Y; Perez-Polo R; Huang MH; Hughes MG; McAdoo DJ; Manickavasagam S; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H813-8. PubMed ID: 17416607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
